Medical Aspects of Chemical Warfare (2008) - The Black Vault

IndexIndexAAberdeen Biological Chemical Agent Disposal Facilitymustard agent container drainage, 597Abood, Leoanticholinergic deliriant research, 424Abramson, Dr. Haroldlysergic acid diethylamide research, 413Acetylcholinesteraseassays for measuring, 702description and mechanism of action, 158, 693nerve agent effect on, 158, 244, 316, 693–694ACGIH. See American Conference of Governmental IndustrialHygienistsAChE. See AcetylcholinesteraseAcland, K.M.uses of lasers in dermatological practice, 284Acticoatmustard agent injury dressing, 280Activated charcoalbrevetoxin intoxication treatment, 630palytoxin intoxication treatment, 620saxitoxin treatment, 627tetrodotoxin treatment, 627Active topical skin protectantcriteria for, 531–532development of, 531Acute exposure guidance levelsfor chemical agents, 143Acute respiratory distress syndromesulfur dioxide and, 345toxic industrial chemicals and, 354–355Adams, Maj. Robertdiphenylaminearsine discovery, 464AEF. See American Expeditionary ForcesAEGLs. See Acute exposure guidance levelsAfghanistanSeptember 11, 2001, terrorist attacks and, 65, 129Afghanistan Warchemical weapons and, 62AFS. See Alternative footwear systemAge factorsbutyrylcholinesterase activity, 164erythrocyte cholinesterase, 164Agency for Toxic Substances and Diseases RegistryHazardous Substance Emergency Events Surveillance System,540Agent Orangeestimation of injuries from, 428Vietnam War and, 341Aghajanian, GeorgeLSD research, 417Aharoni, A.human paraoxonase 1 research, 251Airplanessmoke tanks, 120used for chemical attacks, 26, 118–119Aisne defensivechemical attacks, 29Aisne-Marne offensivechemical attacks, 30–31division field hospitals, 95medical personnel as victims, 102US participation (figure), 31Al Qaedachemical weapons and, 129, 145compared with Aum Shinrikyo, 129description, 129Alexander, Lt. Col. StewartBari disaster and, 105Alkyl methylphosphonic acidsnerve agents and, 694, 695, 696, 698Alkyl MPAs. See Alkyl methylphosphonic acidsAlphabet Bomberchemical attack description, 127Alprazolamincapacitating effects, 420Alternative footwear systemdescription, 573Alzheimer’s diseaseanticholinesterase drug treatment, 158, 704memantine treatment, 228physostigmine treatment, 704tetrahydroaminacridine treatment, 426Ambros, Ottosarin research, 47, 156views on chemical warfare, 49American Academy of Pediatricsforms of terrorism that require immediate attention, 656resources, 683–684American Burn Associationcriteria for chemical burn injuries, 278American Conference of Governmental Industrial Hygienists2-chlorobenzylidene malononitrile exposure guidelines, 447American Expeditionary Forces. See also US Army Medical DepartmentAisne-Marne Offensive and, 30–31Battle of Belleau Wood and, 28, 29–30Battle of Cambrai and, 24–25Battle of Cantigny and, 27, 29Battle of Chateau-Thierry and, 28, 29Battles of Sommervillier and Ansauville and, 25–26Champagne-Marne defensive and, 30chemical warfare casualties, 41–42earliest reported description involving chemical warfare on(exhibit), 22first projector attack on (exhibit), 26Headquarters, First Army Corps, memorandum on the evacuationof sick and wounded, 1918 (exhibit), 98Lys defensive and, 26–27major defensive campaigns, 1918 (table), 89major offensive campaigns of the AEF, 1918 (table), 101Meuse-Argonne campaign and, 33, 36Oise-Aisne offensive and, 321st Gas Regiment, 22, 37secret field order no. 41, annex no. 7, issued by the Fifth Division,September 9, 1918 (exhibit), 100World War I AEF in offensive and defensive battles involvingchemical warfare (table), 23American Heart AssociationPediatric Advanced Life Support Course, 682recommended values for safe cardiovascular function (table),542Aminophyllineincapacitating agent exposure treatment, 471phosgene inhalation treatment, 354Amitai, Y.use of atropine in the pediatric population research, 663–664AMLs. See Area medical laboratoriesAmmoniaxxvii